pyrroles has been researched along with Cancer of the Retina in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erginay, A; Gaudric, A; Girmens, JF; Massin, P; Richard, S; Scigalla, P | 1 |
| Adams, C; Braybrooke, JP; Cattell, E; Deplanque, G; Frith, P; Harris, AL; Huson, SM; Madhusudan, S; Moore, N; Price, P; Scigalla, P; Taylor, M; Tsaloumas, MD | 1 |
1 trial(s) available for pyrroles and Cancer of the Retina
| Article | Year |
|---|---|
Antiangiogenic therapy for von Hippel-Lindau disease.
Topics: Adult; Angiogenesis Inhibitors; Brain Neoplasms; Female; Hemangioblastoma; Humans; Indoles; Male; Middle Aged; Pyrroles; Retinal Neoplasms; Spinal Cord Neoplasms; Treatment Outcome; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2004 |
1 other study(ies) available for pyrroles and Cancer of the Retina
| Article | Year |
|---|---|
Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.
Topics: Adult; Angiogenesis Inhibitors; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Indoles; Infusions, Intravenous; Macular Edema; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Retinal Neoplasms; Visual Acuity; von Hippel-Lindau Disease | 2003 |